Shares of Evogene Ltd (NASDAQ:EVGN) reached a new 52-week low on Thursday . The company traded as low as $2.37 and last traded at $2.39, with a volume of 2732 shares trading hands. The stock had previously closed at $2.40.
Separately, ValuEngine upgraded Evogene from a “hold” rating to a “buy” rating in a research note on Wednesday, November 7th.
An institutional investor recently raised its position in Evogene stock. Vanguard Group Inc. lifted its position in shares of Evogene Ltd (NASDAQ:EVGN) by 11.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 514,089 shares of the biotechnology company’s stock after purchasing an additional 50,823 shares during the period. Vanguard Group Inc. owned about 2.00% of Evogene worth $1,599,000 at the end of the most recent reporting period. Institutional investors own 35.29% of the company’s stock.
Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States, Germany, and internationally. It operates through three segments: Evogene, Evofuel, and Biomica. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.
Featured Article: Conference Calls
Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.